ERYTECH annuncia la presentazione dei poster in occasione della conferenza annuale ASCO 2020

    NEXT STORY
    G1 Therapeutics Announces Flexible Credit Financing for Up to $100 Million with Hercules Capital
    PREV STORY
    Michael White, Ph.D. joins Samumed as Chief Scientific Officer
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Corporate Update

    SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage ...

    author_avatar
    NASDAQ Market News

    Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of Approximately $525 Million of Common Stock

    author_avatar
    NASDAQ Market News

    Viela Bio Announces Final Results from Phase 1b Trial of VIB7734 in Patients with Cutaneous Lupus Erythematosus

    author_avatar
    NASDAQ Market News